Previous 10 | Next 10 |
3 Penny Stocks To Watch In August 2020 When you talk about finding penny stocks to buy, where do you usually start looking? I’m sure you’ve got some type of basic scanning strategy. You may also have your “go-to” websites to get some info – hopefully PennyS...
Image source: The Motley Fool. Agenus Inc (NASDAQ: AGEN) Q2 2020 Earnings Call Aug 6, 2020 , 8:30 a.m. ET Operator Continue reading
Agenus Inc. (AGEN) Q2 2020 Earnings Conference Call August 06, 2020 08:30 AM ET Company Participants Jennifer Buell - President and COO Garo Armen - Chairman and CEO Bree Wilky - Director, Sarcoma Translational Research Program at University of Colorado Cancer Center Julie DeSa...
Agenus (NASDAQ: AGEN ) : Q2 GAAP EPS of -$0.28 misses by $0.01 . More news on: Agenus Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
LEXINGTON, Mass. , Aug. 6, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapy, adjuvants, and vaccines designed to activate immune response to cancers and infections, today provided an R&D ...
LEXINGTON, Mass., Aug. 4, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapy, adjuvants, and vaccines designed to activate immune response to cancers and infections, announced today th...
Volatility watch: Short interest is in an uptrend for Vale (NYSE: VALE ) , Nokia (NYSE: NOK ) , United Airlines (NASDAQ: UAL ) , Micron Technology (NASDAQ: MU ) and Denbury Resources (NYSE: DNR ) , while GameStop (NYSE: GME ) , National Beverage (NASDAQ: FIZZ ) and Dillard's (NYSE:...
LEXINGTON, Mass. , July 29, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapy, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced it will provid...
LEXINGTON, Mass. , July 28, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with an extensive pipeline of agents designed to activate immune response to cancers, today announced the closing of a $20 million equity investment, at $4.03 per share, by Be...
LEXINGTON, Mass., July 21, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, adoptive cell therapies and cancer vaccines, announced today that Dr. J...
News, Short Squeeze, Breakout and More Instantly...
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its second quarter 2024 financial results before the market opens on Thursday, August 8, 2024. Agenus executives will host a co...
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 46.5% to $0.2183 on volume of 404,016,812 shares NVIDIA Corporation (NVDA) rose 2.6% to $121.09 on volume of 317,123,916 shares PROSHARES TRUST (SQQQ) rose 1.5% to $8.23 on volume of 207,449,647 shares Max...
2024-07-18 12:11:22 ET Agenus Inc (NASDAQ: AGEN) faced a dramatic decline in its stock price on Thursday, plummeting more than 50%, following the US Food and Drug Administration (FDA’s) decision to advise against pursuing accelerated approval for its BOT/BAL colorectal cance...